Skip to main content
. 2003 Mar 3;22(5):1047–1057. doi: 10.1093/emboj/cdg096

Table I. Invasion of transfected parasites into enzyme-treated erythrocytes.

Erythrocyte treatmenta Parasiteb
  3D7 3D7Δ2b1 3D7Δ2b2 3D7Δ2a1 3D7Δ2a2 D10
Low trypsin/chymotrypsin 22.8 ± 7.6 70.5 ± 7.7c 65.5 ± 12.9c 18.1 ± 4.8 14.1 ± 2.6 58.0 ± 5.8c
Neuraminidase/low trypsin 23.0 ± 6.9 3.9 ± 0.6c 3.3 ± 0.4c 24.5 ± 6.0 21.9 ± 4.9 10.26 ± 2.3c
Chymotrypsin 67.0 ± 9.1 105.3 ± 9.4c 113.9 ± 14.3c 70.1 ± 10.1 65.3 ± 15.1 99.8 ± 5.9c
Low trypsin 93.5 ± 9.0 63.3 ± 7.8c 61.7 ± 9.7c 80.8 ± 6.7 93.0 ± 14.0 85.9 ± 7.3
Neuraminidase 79.2 ± 8.5 58.2 ± 8.7c 47.5 ± 6.3c 73.9 ± 7.1 82.7 ± 14.9 74.3 ± 11.4

aRed blood cells were treated with the enzymes indicated, as described in Materials and methods, before testing in merozoite invasion assays.

bFigures are the percentage invasion compared with invasion of 3D7 into untreated blood cells, and errors are 95% confidence limits. The data were from 6–14 independent experiments all carried out in triplicate. In the experiments, the starting parasitemia was 0.5% and the final parasitemia was between 3 and 6% for untreated erythrocytes.

cSignificantly different invasion when compared with 3D7.